Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVAH NASDAQ:CELC NYSE:HIMS NYSE:PACS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVAHAveanna Healthcare$7.33$6.76$3.73▼$10.32$1.60B1.931.64 million shs1.43 million shsCELCCelcuity$138.23$121.56$10.26▼$151.02$6.74B0.091.26 million shs661,189 shsHIMSHims & Hers Health$23.71-0.2%$24.03$13.74▼$70.43$5.41B2.4325.09 million shs14.75 million shsPACSPACS Group$37.78+0.1%$34.66$7.50▼$43.08$5.97B-0.03935,357 shs955,151 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVAHAveanna Healthcare0.00%-5.05%+11.91%+1.81%+37.78%CELCCelcuity0.00%+0.40%+14.21%+31.46%+1,224.04%HIMSHims & Hers Health0.00%-5.40%-22.57%+53.31%-56.80%PACSPACS Group0.00%+0.64%+6.83%-7.36%+285.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVAHAveanna Healthcare$7.33$6.76$3.73▼$10.32$1.60B1.931.64 million shs1.43 million shsCELCCelcuity$138.23$121.56$10.26▼$151.02$6.74B0.091.26 million shs661,189 shsHIMSHims & Hers Health$23.71-0.2%$24.03$13.74▼$70.43$5.41B2.4325.09 million shs14.75 million shsPACSPACS Group$37.78+0.1%$34.66$7.50▼$43.08$5.97B-0.03935,357 shs955,151 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVAHAveanna Healthcare0.00%-5.05%+11.91%+1.81%+37.78%CELCCelcuity0.00%+0.40%+14.21%+31.46%+1,224.04%HIMSHims & Hers Health0.00%-5.40%-22.57%+53.31%-56.80%PACSPACS Group0.00%+0.64%+6.83%-7.36%+285.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVAHAveanna Healthcare 2.58Moderate Buy$10.5043.25% UpsideCELCCelcuity 2.83Moderate Buy$149.308.01% UpsideHIMSHims & Hers Health 2.12Hold$28.9021.88% UpsidePACSPACS Group 2.71Moderate Buy$48.0027.06% UpsideCurrent Analyst Ratings BreakdownLatest AVAH, CELC, PACS, and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026HIMSHims & Hers Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$23.005/22/2026HIMSHims & Hers Health Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$18.00 ➝ $23.005/20/2026AVAHAveanna Healthcare Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$8.00 ➝ $9.005/19/2026CELCCelcuity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/19/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$30.00 ➝ $28.005/18/2026PACSPACS Group Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$50.00 ➝ $52.005/18/2026CELCCelcuity HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$165.00 ➝ $185.005/18/2026AVAHAveanna Healthcare BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$9.50 ➝ $9.005/15/2026CELCCelcuity Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$150.00 ➝ $183.005/15/2026AVAHAveanna Healthcare Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$9.00 ➝ $10.005/15/2026AVAHAveanna Healthcare StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$10.00 ➝ $11.00(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVAHAveanna Healthcare$2.43B0.66$0.69 per share10.63$1.10 per share6.66CELCCelcuityN/AN/AN/AN/A$1.10 per shareN/AHIMSHims & Hers Health$2.35B2.30$0.84 per share28.38$1.96 per share12.10PACSPACS Group$5.29B1.13$1.60 per share23.62$6.58 per share5.74Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVAHAveanna Healthcare$225.03M$1.186.2111.450.8710.37%124.68%7.07%8/6/2026 (Estimated)CELCCelcuity-$177.04M-$3.90N/A3,455.75N/AN/A-244.61%-50.22%8/13/2026 (Estimated)HIMSHims & Hers Health$128.37M-$0.09N/A48.3946.09-0.56%6.10%1.52%8/10/2026 (Estimated)PACSPACS Group$191.54M$1.5624.2215.481.154.49%26.47%4.36%8/10/2026 (Estimated)Latest AVAH, CELC, PACS, and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026AVAHAveanna Healthcare$0.13$0.18+$0.05$0.19$613.22 million$647.92 million5/14/2026Q1 2026CELCCelcuity-$1.07-$0.97+$0.10-$0.97$2.94 millionN/A5/11/2026Q1 2026HIMSHims & Hers Health$0.04-$0.40-$0.44-$0.40$616.84 million$608.10 million5/11/2026Q1 2026PACSPACS Group$0.42$0.50+$0.08$0.50$1.36 billion$1.42 billion3/25/2026Q4 2025CELCCelcuity-$1.06-$0.97+$0.09-$0.97$1.28 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVAHAveanna HealthcareN/AN/AN/AN/AN/ACELCCelcuityN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/APACSPACS GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVAHAveanna Healthcare5.351.471.47CELCCelcuity6.0412.3112.31HIMSHims & Hers Health2.181.691.56PACSPACS Group0.270.990.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVAHAveanna Healthcare87.96%CELCCelcuity63.33%HIMSHims & Hers Health63.52%PACSPACS GroupN/AInsider OwnershipCompanyInsider OwnershipAVAHAveanna Healthcare5.30%CELCCelcuity13.33%HIMSHims & Hers Health11.76%PACSPACS Group70.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVAHAveanna Healthcare35,500217.76 million206.21 millionOptionableCELCCelcuity4048.77 million42.27 millionOptionableHIMSHims & Hers Health2,442227.94 million201.13 millionOptionablePACSPACS Group47,455158.27 million47.32 millionOptionableAVAH, CELC, PACS, and HIMS HeadlinesRecent News About These CompaniesJohn Todd Mitchell Sells 27,389 Shares of PACS Group (NYSE:PACS) StockMay 21, 2026 | americanbankingnews.comJohn Todd Mitchell Sells 52,763 Shares of PACS Group (NYSE:PACS) StockMay 21, 2026 | americanbankingnews.comUBS Group AG Sells 175,803 Shares of PACS Group, Inc. $PACSMay 21, 2026 | marketbeat.comInsider Selling: PACS Group (NYSE:PACS) Insider Sells 27,389 Shares of StockMay 20, 2026 | insidertrades.comPACS Group's (NYSE:PACS) Performance Is Even Better Than Its Earnings SuggestMay 18, 2026 | finance.yahoo.comPACS Group, Inc. (NYSE:PACS) Receives Consensus Recommendation of "Buy" from AnalystsMay 16, 2026 | americanbankingnews.comPACS Group (PACS) Is Up 22.1% After Q1 Beat, Guidance Hike and Buyback LaunchMay 14, 2026 | finance.yahoo.comPACS Group Q1 Earnings Call HighlightsMay 14, 2026 | marketbeat.comPACS Group: Strong Comeback That's Backed By Improving FundamentalsMay 13, 2026 | seekingalpha.comWhy PACS Group Stock Surged TodayMay 12, 2026 | fool.comPACS Group, Inc. (PACS) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comPACS Group, Inc. 2026 Q1 - Results - Earnings Call PresentationMay 12, 2026 | seekingalpha.comPACS Group, Inc. (PACS) Q1 Earnings and Revenues Surpass EstimatesMay 11, 2026 | zacks.comPACS Group, Inc. Reports First Quarter 2026 ResultsMay 11, 2026 | businesswire.comPACS vs. MEDP: Which Stock Is the Better Value Option?May 11, 2026 | zacks.comPACS Group, Inc. $PACS Stake Increased by Vanguard Group Inc.May 11, 2026 | marketbeat.comPACS Group (NYSE:PACS) Raised to "Buy" at Wall Street ZenMay 10, 2026 | marketbeat.comPACS Group Inc (PACS) Q1 2026 Earnings Report Preview: What To ExpectMay 8, 2026 | finance.yahoo.comPACS Group Intends to Release First Quarter 2026 Earnings on Monday, May 11, 2026, and Host a Call to Discuss Financial Results on Tuesday, May 12, 2026May 5, 2026 | businesswire.comA new class of super PACs is emerging. Voters are wary.May 5, 2026 | politico.comPPACS Group (NYSE:PACS) Rating Lowered to Hold at Wall Street ZenMay 2, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhat the FDA's Latest Proposal Means for Lilly, Novo, and HimsBy Leo Miller | May 7, 2026Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusBy Jessica Mitacek | May 8, 2026Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?By Jessica Mitacek | May 12, 2026Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansBy Leo Miller | April 28, 2026The Silver Lining of Last Week's Hims & Hers Earnings MissBy Jessica Mitacek | May 21, 2026AVAH, CELC, PACS, and HIMS Company DescriptionsAveanna Healthcare NASDAQ:AVAH$7.33 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$7.50 +0.18 (+2.39%) As of 05/22/2026 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Celcuity NASDAQ:CELC$138.23 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$136.50 -1.73 (-1.25%) As of 05/22/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.Hims & Hers Health NYSE:HIMS$23.71 -0.04 (-0.16%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$23.67 -0.04 (-0.19%) As of 05/22/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.PACS Group NYSE:PACS$37.78 +0.03 (+0.07%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$38.34 +0.57 (+1.50%) As of 05/22/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
